Abhijit P Limaye MD
Professor, Medicine, University of Washington School of Medicine
Join to View Full Profile
513 Parnassus AveSan Francisco, CA 94143
Phone+1 415-476-9362
Fax+1 415-476-9364
Dr. Limaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonResidency, Internal Medicine, 1995 - 1996- University of WashingtonFellowship, Infectious Disease, 1994 - 1995
Mass General Brigham/Massachusetts General HospitalResidency, Internal Medicine, 1992 - 1994- University of Washington School of MedicineClass of 1992
Certifications & Licensure
WA State Medical License 1994 - 2027
CA State Medical License 2024 - 2026
American Board of Internal Medicine Infectious Disease
Awards, Honors, & Recognition
- Regional Top Doctor Castle Connolly, 2014
Clinical Trials
- CMV Antiviral Prevention Strategies in D+R-Liver Transplants ("CAPSIL") Start of enrollment: 2012 Oct 29
Publications & Presentations
PubMed
- 21 citationsAre we underestimating the quality of aviremic hepatitis C-positive kidneys? Time to reconsider.Lena Sibulesky, C. E. Kling, Christopher D. Blosser, Christopher K. Johnson, Ajit P. Limaye
American Journal of Transplantation. 2018-10-01 - 54 citationsUtilization of Organs From Donors According to Hepatitis C Antibody and Nucleic Acid Testing Status: Time for ChangeCatherine E. Kling, James D. Perkins, Charles S. Landis, Ajit P. Limaye, Lena Sibulesky
American Journal of Transplantation. 2017-11-01 - 99 citationsRisk Factors and Outcomes of Ganciclovir-Resistant Cytomegalovirus Infection in Solid Organ Transplant Recipients.Cynthia E. Fisher, Janine L Knudsen, Erika D. Lease, Keith R. Jerome, Robert M. Rakita
Clinical Infectious Diseases. 2017-07-01
Press Mentions
New Horizons in Infectious Disease Treatment and Prevention in Immunocompromised PatientsJune 23rd, 2025
Grant Support
- Kidney transplant Preemptive therapy or Prophylaxis (KPoP) for CMVPreventionin D+R- RecipientsUNIVERSITY OF CALIFORNIA, SAN FRANCISCO2024–2031
- Cytomegalovirus (CMV) Vaccine in Orthotopic Liver Transplant candidates (COLT)UNIVERSITY OF WASHINGTON2021–2028
- 1/2 Ganciclovir to Prevent Reactivation of Cytomegalovirus in Patients with Acute Respiratory Failure and SepsisFRED HUTCHINSON CANCER CENTER2020–2027
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
